This phase III trial studies how well combination chemotherapy and surgery work in treating young patients with Wilms tumor. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Giving combination chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving it after surgery may kill any tumor cells that remain after surgery.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Event-Free Survival (EFS)
Timeframe: 4 years from study enrollment
Kidney Preservation After Preoperative Chemotherapy
Timeframe: 12 weeks from study entry
Number of Patients Without Complete Removal of at Least One Kidney
Timeframe: 12 weeks from the study entry
Percentage of Patients Who Experienced Partial Nephrectomy After Preoperative Chemotherapy
Timeframe: 12 weeks from study entry
Percentage of Patients Who Had Definitive Surgical Treatment
Timeframe: 12 weeks from study entry